Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, with additional offices in Beijing, Suzhou, and Hong Kong. Founded in 2006, the firm specializes in investing in early to growth-stage companies across various sectors, including healthcare, information technology, consumer products, media, and clean technology. Qiming has established itself as a leading investment firm in China, managing multiple funds with over $1 billion in assets. The firm focuses on supporting innovative entrepreneurs and companies that demonstrate high growth potential, particularly in the technology and healthcare landscapes. Through its strategic investments, Qiming aims to foster the development of new business models and technologies, contributing to the dynamic entrepreneurial ecosystem in China.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Kan Chen

Partner

Liwen Chen

Associate

Nan Chen

Principal

David Chu

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Associate

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho Ph.D

Venture Partner

William Hu

Managing Partner

Duane Kuang

Founding Managing Partner

Nisa Leung

Managing Partner

Lisa Li

Investor

Dingzheng Li

Vice President

Jing Liu

Associate

Chang Liu

Associate

Bin Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will Mcconnell

Principal

Mark McDade

Co-Founder and Managing Partner

Gary Rieschel

Founder and Managing Partner

Motao Sun

Associate

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Rachel Wang

Venture Partner

Xin Wang

Investor

James Wang

Venture Partner

Gillian Xu

RMB funds CFO

Kuantai Yeh

Partner

Peter (Ming) Yin

Principal, Cleantech

Janet Yu Ph.D

Partner

Liang Yuyu

Managing Partner

Oscar Zhang

Principal

Yafeng Zhou

Associate

Alex Zhou

Managing Partner

Zhiyuan Zhou

Investor

Zhifeng Zhou

Managing Partner

Yiqing Zhu

Associate

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Phillip DiGiacomo Ph.D

Principal

Past deals in Health Care

Soda Health

Series A in 2022
Soda Health is a healthcare technology company dedicated to addressing health inequities and promoting a healthier America. The company offers a technology platform designed to help individuals identify, access, and pay for essential resources that support their health and well-being. By providing personalized benefits and streamlining the reimbursement process, Soda Health enables customers to effectively bridge the gap between medical claims and retail payments, making healthcare more accessible and affordable.

Boulder Care

Series B in 2022
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.

Wowjoy Technology

Series A in 2022
Wowjoy Technology develops a platform to provide data-driven medical services. The firm is headquartered in Hangzhou, China.

Shanzhen

Series D in 2021
Shanzhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups and personalized health management plans, alongside insurance options. Additionally, Shanzhen offers a range of medical examination services and data finance products aimed at tackling the challenges posed by an aging population and the rising incidence of chronic diseases. By prioritizing the well-being of elderly patients, Shanzhen aims to enhance their quality of life, enabling them to lead happier and healthier lives.

Zeen Health

Venture Round in 2021
Zeen Health is a digital therapeutics company that provides mental health services. Zeen Health was founded in 2019 and was headquartered in Shenzhen, China.

Wowjoy Technology

Series A in 2021
Wowjoy Technology develops a platform to provide data-driven medical services. The firm is headquartered in Hangzhou, China.

Lingyi Zhihui

Series B in 2021
Zuoshouyisheng's AI ​​doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.

Soda Health

Seed Round in 2021
Soda Health is a healthcare technology company dedicated to addressing health inequities and promoting a healthier America. The company offers a technology platform designed to help individuals identify, access, and pay for essential resources that support their health and well-being. By providing personalized benefits and streamlining the reimbursement process, Soda Health enables customers to effectively bridge the gap between medical claims and retail payments, making healthcare more accessible and affordable.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

LetsGetChecked

Series D in 2021
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, NY, with tests covering general wellness, sexual health, women's health and men's health, and is available nationwide, as well as in Canada and Europe.

IntoCare

Series D in 2021
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

Health Biotech

Series B in 2021
Beijing Health Biotech Co. Ltd. specializes in the development of diagnostic and therapeutic products aimed at the diagnosis, treatment, and monitoring of Alzheimer's disease. Founded in 2016 and based in Beijing, the company employs advanced mass spectrometry technology, specifically liquid chromatography-mass spectrometry, to facilitate early diagnosis and treatment. Its product offerings include a range of diagnostic tests for various conditions, including Alzheimer's disease, cardiovascular disease, and genetic metabolic disorders. In addition, the company provides therapeutic drug monitoring, neonatal genetic metabolic disease screening, and clinical testing services. Through its innovations, Health Biotech seeks to aid healthcare professionals in enhancing patient outcomes, particularly in improving cognitive abilities and delaying the onset of Alzheimer's disease.

Hope Medicine

Series B in 2021
Hope Medicine focuses on researching, developing, and commercializing innovative biopharmaceuticals aimed at enhancing the quality of life for patients with various prevalent diseases. The company specializes in translational medicine, utilizing insights from global research initiatives to create monoclonal antibodies, protein drugs, and other therapeutic options targeting endocrine, cardiovascular, and metabolic disorders. By addressing the needs of underserved patient populations, Hope Medicine strives to improve health outcomes and provide access to effective and affordable treatments.

Just Medical

Series B in 2021
Just Medical is a developer and manufacturer of orthopedic medical devices, specializing in artificial orthopedic implants and systems. The company is dedicated to research and development in orthopedics, producing a range of products including artificial hip joints, artificial knee joints, internal fixation devices, and orthopedic surgical instruments. By focusing on advanced technology, Just Medical aims to enhance the quality of orthopedic treatment and improve surgical efficiency for healthcare providers and their patients.

SinoUnited Health

Series C in 2021
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

ET Healthcare

Series G in 2021
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

Fucunbao

Series C in 2021
Developer and operator of an online insurance and medical portal platform intended to serve the rural communities in China. The company's platform allows users to pay for insurance online, create reimbursement plans, and identify disease types online, providing easy access to insurance and online medical services for rural communities in China. The company utilizes government funding and resources to subsidize insurance and medical bills, alleviating poverty caused by medical challenges in rural communities.

Medilink-Global

Series A in 2021
MediLink-Global specializes in healthcare benefits management, offering third-party administration solutions to health insurance providers and corporate organizations. The company delivers a variety of services, including online pre-consultation eligibility verification, claims data capture and validation after consultations, and payment processing. Additionally, MediLink-Global facilitates administrative arrangements for financial guarantees and conducts post-admission follow-up, ensuring effective communication regarding any disapproval or non-admissibility of medical diagnoses. Through these comprehensive services, MediLink-Global supports its clients in managing healthcare benefits efficiently.

IntoCare

Secondary Market in 2021
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

Miaoshou Doctor

Series E in 2021
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Shukun

Series B in 2020
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

New Horizon Health

Series E in 2020
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

Miaoshou Doctor

Series D in 2020
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Shukun

Series B in 2020
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

LetsGetChecked

Series C in 2020
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, NY, with tests covering general wellness, sexual health, women's health and men's health, and is available nationwide, as well as in Canada and Europe.

New Horizon Health

Series D in 2020
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

Shulan Health

Series C in 2020
Shulan Hospital is a hospital center that provides rehabilitation, nutrition, health examination, and remote-consultation services.

IntoCare

Series C in 2020
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

Yuanxin Huibao

Series A in 2019
Yuanxin Huibao is a health insurance technology service provider. It provides insurance for health care in major areas such as major diseases and chronic diseases. It provides users with more reliable medical and medical services and is more insurance. The company offers solutions such as “product actuarial pricing, risk control, user acquisition and viscosity”.

SinoUnited Health

Series C in 2019
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

Shanzhen

Series D in 2019
Shanzhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups and personalized health management plans, alongside insurance options. Additionally, Shanzhen offers a range of medical examination services and data finance products aimed at tackling the challenges posed by an aging population and the rising incidence of chronic diseases. By prioritizing the well-being of elderly patients, Shanzhen aims to enhance their quality of life, enabling them to lead happier and healthier lives.

Huimei Technology

Series C in 2019
Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.

MyHealthTeams

Series B in 2019
MyHealthTeams, Inc. is a San Francisco-based company that creates online social networking platforms for individuals living with chronic health conditions and those who care for them. Founded in 2011, the company operates various platforms, including MyAutismTeam, MyBCTeam, MyMSTeam, and MyCrohnsandColitisTeam, designed to foster connections among users who share similar health challenges. By facilitating these connections, MyHealthTeams enhances patient engagement, allowing users to find support and share experiences with others who understand their daily struggles. The company has developed over 30 distinct social networks, serving approximately 90% of the chronic condition population across 13 countries.

Bondent Technology

Series D in 2019
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

Yuanxin Huibao

Series A in 2019
Yuanxin Huibao is a health insurance technology service provider. It provides insurance for health care in major areas such as major diseases and chronic diseases. It provides users with more reliable medical and medical services and is more insurance. The company offers solutions such as “product actuarial pricing, risk control, user acquisition and viscosity”.

New Horizon Health

Series C in 2019
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

SinoUnited Health

Series B in 2019
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

LetsGetChecked

Series B in 2019
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, NY, with tests covering general wellness, sexual health, women's health and men's health, and is available nationwide, as well as in Canada and Europe.

Anxin Doctor

Series B in 2019
Anxin Doctor is a mobile healthcare platform focused on maternal and pediatric health. It connects patients with obstetricians, gynecologists, and pediatricians through its application, which facilitates access to healthcare advice and clinical appointment bookings. By bridging the gap between patients and healthcare professionals, Anxin Doctor aims to enhance health outcomes for mothers and children, ensuring timely and efficient medical care.

FirstGrid

Seed Round in 2018
Shanghai Firstgrid Technology Co., Ltd., founded in 2016 and headquartered in Shanghai, China, specializes in medical treatment cloud services and supply chain management for the healthcare industry. The company develops a platform that digitizes and tracks medical devices, patient information, and physician data, enhancing the accuracy of device usage monitoring. Additionally, FirstGrid collaborates with third-party storage and delivery services to ensure efficient logistics for medical devices. Through its comprehensive database and tracking capabilities, FirstGrid aims to improve the overall management and operational efficiency of the healthcare supply chain in China.

Cardialen

Series B in 2018
Cardialen, Inc., a medical device company that develops a therapy system that detects and treats atrial fibrillation, rapid ventricular tachycardia, and ventricular fibrillation. It offers an implantable device to restore normal heart rhythm and may reduce the potential for high-energy defibrillation shocks. The company was incorporated in 2008 and is based in Minneapolis, Minnesota.

ET Healthcare

Series C in 2018
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

IntoCare

Series B in 2018
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

Madaket

Series B in 2018
Madaket, Inc. is a software as a service (SaaS) provider based in Cambridge, Massachusetts, specializing in solutions for the healthcare industry. The company focuses on automating the healthcare enrollment process, facilitating connections between healthcare providers and payers to efficiently manage administrative tasks. Madaket's platform enhances the accuracy and speed of provider data management, allowing healthcare organizations to save time, reduce manual errors, and monitor enrollment statuses effectively. The company has established exclusive partnerships with entities such as TriZetto Provider Solutions and HealthStream, giving it access to a network of over 300,000 providers, with plans to incorporate an additional 325,000 providers. Founded in 2012 by Mads Kvalsvik, Scott Soderstrom, Jim Dougherty, and Ted Achtem, Madaket aims to transform healthcare administration through innovative technology.

Core Medical

Series A in 2018
Core Medical (Beijing) Co., Ltd. is a contract research organization (CRO) founded in 2013 and based in Beijing, China. The company specializes in clinical professional services focused on new technologies and innovative products within the cardiovascular sector. Core Medical offers a range of services, including animal testing, type testing, First-in-Man (FIM) studies, human studies, and statistics and data management for clinical research. By providing these services, Core Medical helps companies in the cardiovascular field evaluate and validate their products, facilitating advancements in medical technology.

Miaoshou Doctor

Series C in 2018
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Bondent Technology

Series C in 2018
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

LetsGetChecked

Series A in 2018
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, NY, with tests covering general wellness, sexual health, women's health and men's health, and is available nationwide, as well as in Canada and Europe.

Innostic

Series A in 2018
Innostic distributes and supplies medical device consumable materials. The company is based in Beijing, China.

Twine Health

Series A in 2017
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool. The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more. Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.

VR Medical

Series B in 2017
VR Medical, established in 2009, is a US-based manufacturer that specializes in providing low-cost, high-quality medical devices. The company supports medical device manufacturers and distributors by offering a comprehensive solution for new product development, contract manufacturing, and secure product distribution in China. VR Medical's focus includes disposable products and electronic devices tailored for private labels, serving various medical markets such as respiratory care, critical care, blood purification, and advanced wound care. Through its innovative approach, the company enables clients to enhance their offerings while maintaining efficiency and cost-effectiveness in the production process.

New Horizon Health

Series B in 2017
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

MyHealthTeams

Series A in 2017
MyHealthTeams, Inc. is a San Francisco-based company that creates online social networking platforms for individuals living with chronic health conditions and those who care for them. Founded in 2011, the company operates various platforms, including MyAutismTeam, MyBCTeam, MyMSTeam, and MyCrohnsandColitisTeam, designed to foster connections among users who share similar health challenges. By facilitating these connections, MyHealthTeams enhances patient engagement, allowing users to find support and share experiences with others who understand their daily struggles. The company has developed over 30 distinct social networks, serving approximately 90% of the chronic condition population across 13 countries.

Miaoshou Doctor

Series B in 2017
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Twine Health

Series A in 2017
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool. The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more. Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.

ET Healthcare

Venture Round in 2017
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

ZappRx

Series B in 2017
ZappRx, Inc. is a digital health company based in Boston, Massachusetts, that specializes in a cloud-based platform designed to streamline the management of specialty medications. Founded in 2012, the company provides a secure online environment where healthcare providers, specialty pharmacies, and biopharma companies can collaborate efficiently. Its platform automates the prescription and prior authorization processes, facilitating communication among patients, physicians, and pharmacists while reducing reliance on traditional methods such as faxes and phone calls. By consolidating essential information related to specialty prescribing—including pharmacy details, payer requirements, and clinical history—the platform enhances the efficiency and transparency of healthcare delivery, particularly in the fields of pulmonary, cardiology, and gastroenterology. ZappRx operates as a subsidiary of Allscripts Healthcare Solutions, Inc. as of June 2019.
Qiang Sen International Community Medical (QSICM) operates community healthcare service centers. The Clinic offers internal medicine, pediatrics, gynecology, stomatology, laboratory, ultrasonography, and electrocardiography services. QSICM serves patients in China.

IntoCare

Series A in 2017
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

Anxin Doctor

Series B in 2017
Anxin Doctor is a mobile healthcare platform focused on maternal and pediatric health. It connects patients with obstetricians, gynecologists, and pediatricians through its application, which facilitates access to healthcare advice and clinical appointment bookings. By bridging the gap between patients and healthcare professionals, Anxin Doctor aims to enhance health outcomes for mothers and children, ensuring timely and efficient medical care.
LIH Investment & Management manages and invests in rehabilitation medical institutions. The Company serves customers in China. LIH Investment & Management has always been devoted to invest, manage and operate high-quality rehabilitation medical service organization, introduce internationalization concept, technology and mode into China, promote the professional medical rehabilitation service and management and continuous innovation.

Bondent Technology

Series B in 2017
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

Shulan Health

Series B in 2016
Shulan Hospital is a hospital center that provides rehabilitation, nutrition, health examination, and remote-consultation services.

Bondent Technology

Series C in 2016
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.
LIH Investment & Management manages and invests in rehabilitation medical institutions. The Company serves customers in China. LIH Investment & Management has always been devoted to invest, manage and operate high-quality rehabilitation medical service organization, introduce internationalization concept, technology and mode into China, promote the professional medical rehabilitation service and management and continuous innovation.

Junhetang

Series B in 2016
Junhetang operates a network of traditional Chinese medicine (TCM) clinics, providing a range of healthcare services that include herbal medicine, acupuncture, massage, exercise, and dietary therapies. The company combines TCM culture with the expertise of renowned TCM practitioners to deliver personalized medical services. Additionally, Junhetang integrates modern internet services into its offerings, creating an innovative TCM service network that encompasses education, training, medical care, and health maintenance. Headquartered in Nanjing, the company is actively expanding its presence in several major cities across China, including Shanghai, Shenzhen, Chengdu, and Taiyuan.

JHT TCM Clinics

Series B in 2016
JHT TCM Clinics

ET Healthcare

Series B in 2015
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

Junhetang

Series B in 2015
Junhetang operates a network of traditional Chinese medicine (TCM) clinics, providing a range of healthcare services that include herbal medicine, acupuncture, massage, exercise, and dietary therapies. The company combines TCM culture with the expertise of renowned TCM practitioners to deliver personalized medical services. Additionally, Junhetang integrates modern internet services into its offerings, creating an innovative TCM service network that encompasses education, training, medical care, and health maintenance. Headquartered in Nanjing, the company is actively expanding its presence in several major cities across China, including Shanghai, Shenzhen, Chengdu, and Taiyuan.

MedSci

Series A in 2015
MedSci provides strategies, solutions and services to pharmaceutical, biotech and medical device organization and the consumer healthcare industry

WeDoctor

Venture Round in 2014
WeDoctor Holdings (Zhejiang) Co., Ltd. is a prominent medical technology platform based in Hangzhou, China, founded in 2010. The company specializes in developing medical cloud and artificial intelligence solutions that cater to governments, hospitals, and healthcare institutions. WeDoctor provides a comprehensive cloud platform that facilitates both online and offline medical services, including general practice, specialty consultations, and appointment scheduling. Additionally, it operates a managed health services platform known as WeDoctor HMO, aimed at enhancing medical care accessibility and efficiency. By leveraging technology, WeDoctor strives to improve health management for users, positioning itself as a significant player in the health maintenance organization sector. Through its innovative approach, the company aims to serve as a crucial health resource for millions of families.

Arrail Dental Clinic

Series C in 2014
Arrail Dental Clinic, founded in 1998 and based in Beijing, China, specializes in a comprehensive range of oral health care services. The clinic offers treatments in various areas including endodontics, general dentistry, implants, orthodontics, pediatric dentistry, prosthodontics, and periodontics. Additional services encompass toothache treatment, restoration, tooth whitening, elderly teeth care, and hygiene. With thirty branches established in major cities such as Beijing, Shanghai, Shenzhen, Guangzhou, Xiamen, Hangzhou, and Tianjin, Arrail Dental Clinic caters to both domestic and international clients. The clinic also facilitates online appointment services, enhancing accessibility for patients.

VR Medical

Series A in 2014
VR Medical, established in 2009, is a US-based manufacturer that specializes in providing low-cost, high-quality medical devices. The company supports medical device manufacturers and distributors by offering a comprehensive solution for new product development, contract manufacturing, and secure product distribution in China. VR Medical's focus includes disposable products and electronic devices tailored for private labels, serving various medical markets such as respiratory care, critical care, blood purification, and advanced wound care. Through its innovative approach, the company enables clients to enhance their offerings while maintaining efficiency and cost-effectiveness in the production process.

JHT TCM Clinics

Series A in 2013
JHT TCM Clinics
Goodwill Infotech provides clinical information.

Arrail Dental Clinic

Series B in 2011
Arrail Dental Clinic, founded in 1998 and based in Beijing, China, specializes in a comprehensive range of oral health care services. The clinic offers treatments in various areas including endodontics, general dentistry, implants, orthodontics, pediatric dentistry, prosthodontics, and periodontics. Additional services encompass toothache treatment, restoration, tooth whitening, elderly teeth care, and hygiene. With thirty branches established in major cities such as Beijing, Shanghai, Shenzhen, Guangzhou, Xiamen, Hangzhou, and Tianjin, Arrail Dental Clinic caters to both domestic and international clients. The clinic also facilitates online appointment services, enhancing accessibility for patients.

Guokang

Series B in 2010
Guokang Health Management Co., Ltd. is a prominent healthcare service provider based in Shenzhen, China, established in 2005. The company specializes in a wide range of health management services, including general practitioner consultations, illness consultations, chronic disease management, and health record management. Guokang offers both individual and corporate healthcare solutions, partnering with various industries such as banking, insurance, and telecommunications to deliver value-added services. With a significant online presence and a network of service agents across China, Guokang has built a comprehensive healthcare service platform that integrates domestic and international healthcare resources. The company currently serves over 600,000 members, making it the largest healthcare service provider in China, focusing on improving overall health management through innovative programs and partnerships.

Arrail Dental Clinic

Series A in 2010
Arrail Dental Clinic, founded in 1998 and based in Beijing, China, specializes in a comprehensive range of oral health care services. The clinic offers treatments in various areas including endodontics, general dentistry, implants, orthodontics, pediatric dentistry, prosthodontics, and periodontics. Additional services encompass toothache treatment, restoration, tooth whitening, elderly teeth care, and hygiene. With thirty branches established in major cities such as Beijing, Shanghai, Shenzhen, Guangzhou, Xiamen, Hangzhou, and Tianjin, Arrail Dental Clinic caters to both domestic and international clients. The clinic also facilitates online appointment services, enhancing accessibility for patients.

CITIC Pharmaceutical

Series D in 2009
CITIC Pharmaceutical Co., Ltd. (中信医药) is a pharmaceutical service provider that supplies medicine and related consumables to hospitals. It is a large pharmaceutical operation enterprise integrating medicines supply to hospitals, cross-regional commercial distribution, vaccine sale, medical instruments and consumables sale, and medicine retailing service. In recent years, it has become a pharmaceutical service provider in the supply chain with multiple customized integration service. CITIC Pharmaceutical, which is a subsidiary of CITIC Group, was transformed to a joint venture in 2007. It is invested by China Health System whose holding company is Bioveda China fund and CITIC Investment Holdings Ltd.

Guokang

Series A in 2007
Guokang Health Management Co., Ltd. is a prominent healthcare service provider based in Shenzhen, China, established in 2005. The company specializes in a wide range of health management services, including general practitioner consultations, illness consultations, chronic disease management, and health record management. Guokang offers both individual and corporate healthcare solutions, partnering with various industries such as banking, insurance, and telecommunications to deliver value-added services. With a significant online presence and a network of service agents across China, Guokang has built a comprehensive healthcare service platform that integrates domestic and international healthcare resources. The company currently serves over 600,000 members, making it the largest healthcare service provider in China, focusing on improving overall health management through innovative programs and partnerships.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.